Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

AstraZeneca to develop mHealth cardiovascular services

Willwork with Vodafone in a new global partnership

Digital pharmaAstraZeneca has teamed up with telecoms giant Vodafone to develop a range of mHealth services for patients with cardiovascular conditions.

The global deal will see the partners create new mobile and internet-based services to support patients in areas such as medication adherence and self-management.

On the AZ side the project will be led by the pharma company's 'intelligent pharmaceutical group', which will work closely with local AZ marketing teams.  

Andy Jones, the company's VP pharmaceutical innovation, said: “It is really exciting to see the progress being made in this area. This work is an excellent example of collaboration between AstraZeneca and Vodafone.

"Together we believe we are delivering something that will bring real benefit to patients in this important therapeutic area.”

Vodafone will provide the technology, infrastructure and expertise for these services, as well as the ability to capture data from a variety of sources to improve overall engagement between patients and their health care professionals (HCPs).

Patients will also be offered educational material - personalised for their needs - and the overall service package will include coaching and treatment support elements.

Vodafone said it would be designing the services in such a way to ensure they work across geographies and can adapt to local variations in regulations and patient care.

The company has previously partnered with GlaxoSmithKline to improve childhood vaccination rates in Mozambique and its mHealth projects include collaborating on a Kenyan mHealth pilot scheme to improve maternal health information and education.

Vodafone's latest deal comes as Europe awaits publication of the European Commission's mHealth Green Paper, that will seek views on issues like data protection, privacy compliance, patient safety and legal clarity.

21st March 2014

From: Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics